Dendrite International DRTE
-
Three Health-Care IT Stocks for the Future
… Consider Buying" Price IMS Health RX Wide Average $27.00 Allscripts Healthcare MDRX Narrow Average $17.70 Dendrite International DRTE Narrow Above Average $10.20 Trizetto Group TZIX Narrow Average $16.20 Cerner CERN None Average $36 …
-
Dendrite Agrees to Be Acquired
On March 2, French IT services group CEGEDIM announced its plan to buy Dendrite International DRTE for $16 per share. We are raising our fair value estimate to reflect CEGEDIM's offer. Our previous fair value estimate reflected …
-
Dendrite's Outlook Still Murky
Dendrite International DRTE faces a transitional 2007 in its two most important operating segments, and we like little about its long-term strategic fortunes …
-
Dendrite Reports 2Q Results
Dendrite International 's DRTE second-quarter results met our expectations for declining revenue and lower profitability. Our fair value estimate is unchanged …
-
Dendrite under Review
We are placing Dendrite International DRTE under review as we transfer coverage to a new analyst.
-
Cost Overrun Continues at Dendrite
In its first quarter of 2006, Dendrite's DRTE revenue increased 7% year over year on an apples-to-apples basis, driven by strength in its marketing solutions segment …
-
Dendrite's Analyst Day
In a departure from its past, Dendrite DRTE recently hosted an Analyst Day in part to address recent investor concerns stemming from tepid fourth-quarter results. CEO John …
-
Dendrite under Review
We're placing Dendrite DRTE shares under review as we take a fresh look at our assumptions in light of a disappointing fourth quarter that fell well short …
-
Dendrite Warns Over Q4 Earnings
Dendrite DRTE on Thursday issued a negative outlook for the fourth quarter, warning investors of a potential revenue and earnings shortfall …
-
Strong 3Q for Dendrite
… automation software and growing pharmaceutical industry adoption of its interactive marketing tools contributed to Dendrite's DRTE strong performance in the third quarter. Year-over-year sales growth of 15% was driven partly by a robust sales pipeline …